학술논문
Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody–Drug Conjugate
Document Type
Article
Author
Singh, S.; Serwer, L.; DuPage, A.; Elkins, K.; Krimm, M.; Wong, K.; Sagert, J.; Tipton, K.; Moore, S.J.; Huang, Y.; Jang, A.; Ureno, E.; Miller, A.; Patrick, S.; Duvur, S.; Liu, S.; Vasiljeva, O.; Schleyer, S.; Krebber, C.; Viswanathan, S.; Desnoyers, L.; Terrett, J.; Belvin, M.; Kavanaugh, W.M.; Richardson, J.; Chauhan, N.; Ravn, M.; Buchanan, F.; Wang, L.; Li, Y.; Henriques, T.; Badagnani, I.; Jeffries, S.; Leanna, R.; Morgan-Lappe, S.
Source
In: Molecular Cancer Therapeutics . (Molecular Cancer Therapeutics, August 2022, 21(8):1326-1336)
Subject
Language
English
ISSN
15388514
15357163
15357163